Skip to main content
S&P 5007,656.98+0.86%DOW52,573.29+0.98%NASDAQ26,333.03+0.96%BTC$77,267.00+0.58%ETH$2,510.86+2.27%GOLD$4,390.00-0.39%OIL$99.99-2.43%
Smart Investors Daily
cbdMD, Inc. logo

NASDAQ · YCBD

cbdMD, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.48

Up+$0.00 (+0.88%)

Updated Sep 12, 2026, 1:26 PM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
5.58M
P/E ratio
-1.44
Dividend yield
0.00%
52-week range
$0.45 – $2.56
Volume
13.29K
Avg. volume
3.96M

Price performance

YCBD price history

1M range · 20 trading sessions · Daily adjusted prices

YCBD closed at $0.48 after 20 trading sessions, down 2.73% for the selected period.

Last close
$0.48
Period change
-2.73%
Period low
$0.47
Period high
$0.52
Daily close
View OHLC price history
YCBD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 11, 2026$0.4751$0.4919$0.4751$0.482213.29K
Sep 10, 2026$0.48$0.50$0.475$0.47871.62K
Sep 9, 2026$0.486$0.505$0.4745$0.491971.77K
Sep 8, 2026$0.4744$0.4998$0.4744$0.499734.36K
Sep 4, 2026$0.4796$0.4999$0.4746$0.475683.69K
Sep 3, 2026$0.481$0.4902$0.4521$0.481358.75K
Sep 2, 2026$0.4777$0.5149$0.4752$0.49981.81M
Sep 1, 2026$0.4951$0.51$0.491$0.4999113.48K
Aug 31, 2026$0.4977$0.52$0.49$0.4979.2K
Aug 28, 2026$0.5139$0.5139$0.48$0.50153.73K
Aug 27, 2026$0.5201$0.53$0.4971$0.497136.96K
Aug 26, 2026$0.5148$0.5319$0.5101$0.520120.9K
Aug 25, 2026$0.489$0.533$0.489$0.518191.9K
Aug 24, 2026$0.4924$0.5185$0.488$0.48851.9K
Aug 21, 2026$0.4854$0.52$0.4854$0.5089149.12K
Aug 20, 2026$0.4899$0.505$0.4801$0.50538.17K
Aug 19, 2026$0.4998$0.5099$0.485$0.49142.39K
Aug 18, 2026$0.49$0.4905$0.47$0.4742.14K
Aug 17, 2026$0.50$0.50$0.469$0.475100.66K
Aug 14, 2026$0.5645$0.58$0.487$0.4958496.99K

Latest YCBD news

The latest Smart Investors Daily articles mentioning YCBD.

Stock researchCompany · Overview

YCBD research

Overview

Company profile and research snapshot.

Company profile

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
YCBD recent ratings
DateFirmRatingTarget
Aug 17, 2026Maxim GroupHold—
Aug 20, 2025Maxim GroupBuy—
May 22, 2025Maxim GroupBuy—
Oct 5, 2023Maxim GroupBuy—
Jun 18, 2021Cantor FitzgeraldNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 2, 2026

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness

cbdMD, Inc. (NYSE American: YCBD), a leading consumer wellness company, today announced that it has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The acquisition is being conducted through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval and customary closing conditions.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By